Extract from Chairman's letter to shareholder's for rights issue.
"Invion is currently completing its INV103 (ala-Cpn10) and INV102 (nadolol) programs, with pivotal data anticipated within three to four months. Based on recent transactions in the industry it is anticipated that this data will enable the Company to negotiate a strategic investment by a recognised biotech fund, or provide a platform for the sale of the Company or its assets within six months. "
- Forums
- ASX - By Stock
- Morgan's Research
Extract from Chairman's letter to shareholder's for rights...
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IVX (ASX) to my watchlist
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.33M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.2¢ | $6.251K | 2.967M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
47 | 43316984 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 4352691 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
47 | 43316984 | 0.002 |
26 | 29577144 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 4352691 | 8 |
0.004 | 8453485 | 11 |
0.005 | 8422572 | 26 |
0.006 | 2074992 | 8 |
0.007 | 1562000 | 4 |
Last trade - 16.10pm 11/09/2024 (20 minute delay) ? |
Featured News
IVX (ASX) Chart |